Upcoming FDA Reorg Overhauls Office of Regulatory Affairs

The US FDA hopes to make major changes in 2024, including an inspections-focused replacement for the Office of Regulatory Affairs, a new Office of the Chief Medical Officer, and moving labs currently within ORA to the Office of the Chief Scientist.